SEQSTER partners with Antidote Technologies for clinical trial enrollment
Antidote will use SEQSTER’s operating system to improve clinical trial time lines and enhance patient engagement for pharma and life sciences companies.
Antidote will use SEQSTER’s operating system to improve clinical trial time lines and enhance patient engagement for pharma and life sciences companies.
Go to Source
2024-07-09 00:37
Except for the headline, this story has not been edited by Healthcare Central is published from a syndicated feed.
